Science Explorer Back to mapMap
Discussion
Institution · VieCuri Medisch Centrum

Most cited papers from VieCuri Medisch Centrum

VieCuri Medisch Centrum

What are the most cited papers from VieCuri Medisch Centrum?

The most cited paper from VieCuri Medisch Centrum is "Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease" (Paul M. Ridker et al., 2017), with 9,517 citations. Next come "Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol" (1,000) and "2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative" (916).

Showing 50 of 59 papers. Every paper with more than 145 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease Paul M. Ridker et al. · New England Journal of Medicine Open access 27 Aug 2017 9,517
2 Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol Kausik Kumar Ray, Ulf Landmesser, Lawrence A. Leiter et al. · New England Journal of Medicine Open access 17 Mar 2017 1,000
3 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Tuhina Neogi et al. · Annals of the Rheumatic Diseases Open access 10 Sep 2015 916
4 Global cancer incidence in older adults, 2012 and 2035: A population‐based study Sophie Pilleron, Diana Sarfati, Maryska L.G. Janssen-Heijnen et al. · International Journal of Cancer Open access 6 Jul 2018 708
5 Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial Miriam Koopman, Ninja F. Antonini, Joep Douma et al. · The Lancet Jul 2007 633
6 Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial Frederik M. Zimmermann, Angela Ferrara, Nils P. Johnson et al. · European Heart Journal Open access 23 Sep 2015 545
7 Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT) Kim E. Boers et al. · BMJ Open access 21 Dec 2010 538
8 36th International Symposium on Intensive Care and Emergency Medicine R. M. Bateman et al. · Critical Care Open access2,440 authors Apr 2016 531
9 Epidemiology of fractures in the United Kingdom 1988–2012: Variation with age, sex, geography, ethnicity and socioeconomic status Elizabeth Mary Curtis, Robert van der Velde, Rebecca Jane Moon et al. · Bone Open access 8 Mar 2016 470
10 Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial Mette S. van Ramshorst, Anna van der Voort, Erik D. van Werkhoven et al. · The Lancet Oncology Open access 6 Nov 2018 469
11 Bishop Score and Risk of Cesarean Delivery After Induction of Labor in Nulliparous Women F P J Vrouenraets, Frans J.M.E. Roumen, C. Dehing et al. · Obstetrics and Gynecology Apr 2005 451
12 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout Pascal Richette et al. · Annals of the Rheumatic Diseases Open access 5 Jun 2019 446
13 Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial Stefanie de Groot et al. · Nature Communications Open access 23 Jun 2020 347
14 Prevalence of sarcopenia as a comorbid disease: A systematic review and meta-analysis Jacob Pacifico, Milou A.J. Geerlings, Esmee M. Reijnierse et al. · Experimental Gerontology ReviewOpen access 27 Dec 2019 338
15 Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial Kausik Kumar Ray, Roel P T Troquay, Frank L.J. Visseren et al. · The Lancet Diabetes & Endocrinology Open access 5 Jan 2023 322
16 Preoperative therapeutic programme for elderly patients scheduled for elective abdominal oncological surgery: a randomized controlled pilot study JJ Dronkers, H Lamberts, IMMD Reutelingsperger et al. · Clinical Rehabilitation 8 Jun 2010 313
17 Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial Aimée HMM Arits, Klara Mosterd, Brigitte A.B. Essers et al. · The Lancet Oncology 14 May 2013 313
18 Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial Viola Klück, Tim Jansen, M. Janssen et al. · The Lancet Rheumatology Open access 7 Apr 2020 312
19 Reference Population and Marathon Runner Sera Assessed by Highly Sensitive Cardiac Troponin T and Commercial Cardiac Troponin T and I Assays Alma M.A. Mingels, Leo H.J. Jacobs, Etienne Michielsen et al. · Clinical Chemistry Open access 7 Nov 2008 296
20 Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease Mariëlle J. L. Romberg-Camps, Pieter C. Dagnelie, A D M Kester et al. · The American Journal of Gastroenterology 27 Jan 2009 293
21 Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra Tania O. Crișan, Maartje C. P. Cleophas, Marije Oosting et al. · Annals of the Rheumatic Diseases Open access 4 Feb 2015 287
22 Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom study Ruben T. H. M. Larue, Janita E. van Timmeren, Evelyn E.C. de Jong et al. · Acta Oncologica Open access 8 Sep 2017 285
23 Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium Mark van den Boogaard et al. · JAMA Open access 20 Feb 2018 280
24 Appendectomy versus antibiotic treatment for acute appendicitis Ingrid MHA Wilms, Dominique ENM de Hoog, Dianne C de Visser et al. · Cochrane Database of Systematic Reviews Open access Nov 2011 259
25 Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome Dorien J. A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · Breast Cancer Research and Treatment Oct 2013 253
26 Randomized Trial of Four Treatment Approaches for Actinic Keratosis Maud H.E. Jansen, J.P.H.M. Kessels, Patty J. Nelemans et al. · New England Journal of Medicine Open access 6 Mar 2019 250
27 Fatigue and health-related quality of life in inflammatory bowel disease Mariëlle J. L. Romberg-Camps, Yvonne Bol, Pieter C. Dagnelie et al. · Inflammatory Bowel Diseases 12 Apr 2010 248
28 Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? Dorien J. A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · British Journal of Cancer Open access Apr 2015 244
29 Convalescent Plasma for COVID-19. A randomized clinical trial Arvind Gharbharan et al. · medRxiv PreprintOpen access 3 Jul 2020 240
30 Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial Pascale Notten, Arina J. ten Cate‐Hoek, Carsten W. K. P. Arnoldussen et al. · The Lancet Haematology Open access 27 Nov 2019 225
31 Hartmann's procedure versus sigmoidectomy with primary anastomosis for perforated diverticulitis with purulent or faecal peritonitis (LADIES): a multicentre, parallel-group, randomised, open-label, superiority trial Daniël P. V. Lambrichts et al. · ˜The œLancet. Gastroenterology & hepatology Open access178 authors 7 Jun 2019 216
32 Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial Lidy M. J. Pelsser, K. Frankena, Jan Toorman et al. · The Lancet Open access Feb 2011 215
33 Heart failure admissions in adults with congenital heart disease; risk factors and prognosis Anoek Zomer, Ilonca C. H. Vaartjes, Enno Tjeerd van der Velde et al. · International Journal of Cardiology 19 Apr 2013 214
34 Early electroencephalography for outcome prediction of postanoxic coma: A prospective cohort study Barry J. Ruijter, Marleen C. Tjepkema‐Cloostermans, Selma C. Tromp et al. · Annals of Neurology Open access 3 Jun 2019 212
35 Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization Aniek Ag Zee, Kelly van Lieshout, Maaike van der Heide et al. · Cochrane Database of Systematic Reviews Open access 6 Aug 2017 210
36 Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation Robby Nieuwlaat, S. Bertil Olsson, Gregory Y.H. Lip et al. · American Heart Journal 30 May 2007 210
37 Induction of Labor versus Expectant Management in Women with Preterm Prelabor Rupture of Membranes between 34 and 37 Weeks: A Randomized Controlled Trial David P. van der Ham et al. · PLoS Medicine Open access 24 Apr 2012 207
38 Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management Pieter P. A. Lestrade, Jacques F. G. M. Meis, Willem J. G. Melchers et al. · Clinical Microbiology and Infection Open access 20 Dec 2018 204
39 Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer Annelies H. Boekhout et al. · JAMA Oncology Open access 27 Jun 2016 201
40 Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial David P. van der Ham, Jantien L. van der Heyden, Brent C. Opmeer et al. · American Journal of Obstetrics and Gynecology Open access 20 Jul 2012 200
41 Management of Chronic Heart Failure Guided by Individual N-Terminal Pro–B-Type Natriuretic Peptide Targets Luc W.M. Eurlings, Petra E.J. van Pol, Wouter E.M. Kok et al. · Journal of the American College of Cardiology Open access Dec 2010 189
42 Fracture Liaison Service: Impact on Subsequent Nonvertebral Fracture Incidence and Mortality K.M. Huntjens, Tineke A. C. M. van Geel, Joop P. van den Bergh et al. · Journal of Bone and Joint Surgery 19 Feb 2014 187
43 Oil-Based or Water-Based Contrast for Hysterosalpingography in Infertile Women Kim Dreyer et al. · New England Journal of Medicine Open access 18 May 2017 185
44 Osteoporosis, frailty and fracture: implications for case finding and therapy Joop P. van den Bergh, Tineke A. C. M. van Geel, Piet Geusens · Nature Reviews Rheumatology Review 17 Jan 2012 180
45 Human Intestinal Ischemia-Reperfusion–Induced Inflammation Characterized Joep Grootjans, Kaatje Lenaerts, Joep P. M. Derikx et al. · American Journal Of Pathology Open access 26 Mar 2010 180
46 The efficacy of Internet‐based cognitive behavioral therapy for severely fatigued survivors of breast cancer compared with care as usual: A randomized controlled trial Harriët J. G. Abrahams, Marieke F M Gielissen, Rogier Donders et al. · Cancer Open access 16 Jun 2017 175
47 The Effect of an App for Day-to-Day Postoperative Care Education on Patients With Total Knee Replacement: Randomized Controlled Trial Thomas Timmers, Loes Janssen, Walter van der Weegen et al. · JMIR mhealth and uhealth Open access 23 Sep 2019 170
48 Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction Khibar Salah, Susan Stienen, Yigal M. Pinto et al. · Heart Open access 8 Apr 2019 170
49 Depression, Anxiety, and Correlating Factors in Endometriosis: A Systematic Review and Meta-Analysis Esther van Barneveld, Jessica Manders, Frits van Osch et al. · Journal of Women s Health ReviewOpen access 2 Jun 2021 165
50 Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual ERBB2 Blockade in Patients With ERBB2 -Positive Breast Cancer Anna van der Voort, Mette S. van Ramshorst, Erik D. van Werkhoven et al. · JAMA Oncology Open access 20 May 2021 159

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.